Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated (CORT) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CORT · as of Jun 8, 2026
Activity summary
Buy transactions
2
P-Purchase only
Sell transactions
73
12 Months
Buy/Sell ratio
0.03
Buy/Sell (by trades)
Overall sentiment
Corcept Therapeutics Incorporated insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CORT insider buying and selling by quarter
CORT insider selling · CORT insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CORT ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CORT executive sell shares · CORT board member insider trading · CORT insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Guyer William Chief Development Officer | Option | 20,000 | $433K | Form 4 |
| Jun 2, 2026 | Guyer William Chief Development Officer | Sale | 20,000 | $1.41M⚡ | Form 4 |
| Jun 1, 2026 | Lyon Joseph Douglas See Remarks | Award | 537 | — | Form 4 |
| Jun 2, 2026 | Lyon Joseph Douglas See Remarks | Other | 269 | $19K | Form 4 |
| Jun 1, 2026 | Lyon Joseph Douglas See Remarks | Award | 537 | $38K | Form 4 |
| Jun 1, 2026 | Guyer William Chief Development Officer | Award | 877 | — | Form 4 |
| Jun 1, 2026 | Guyer William Chief Development Officer | Award | 877 | $62K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Option | 25,000 | $207K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Sale | 21,069 | $1.48M⚡ | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Award | 615 | — | Form 4 |
| Jun 2, 2026 | Maduck Sean See Remarks | Other | 452 | $32K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Award | 615 | $43K | Form 4 |
| Jun 1, 2026 | Maduck Sean See Remarks | Sale | 3,931 | $278K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Option | 40,000 | $770K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Award | 634 | — | Form 4 |
| Jun 2, 2026 | Mokari Atabak CFO | Other | 395 | $28K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Award | 634 | $45K | Form 4 |
| Jun 1, 2026 | Mokari Atabak CFO | Sale | 40,000 | $2.80M⚡ | Form 4 |
| Jun 1, 2026 | Robb Gary Charles Chief Business Officer | Award | 776 | — | Form 4 |
| Jun 2, 2026 | Robb Gary Charles Chief Business Officer | Other | 358 | $25K | Form 4 |
| Jun 1, 2026 | Robb Gary Charles Chief Business Officer | Award | 776 | $55K | Form 4 |
| May 29, 2026 | BELANOFF JOSEPH K CEO · Director | Gift | 300,000 | — | Form 4 |
| Jun 1, 2026 | BELANOFF JOSEPH K CEO · Director | Sale | 12,837 | $895K | Form 4 |
| May 29, 2026 | BELANOFF JOSEPH K CEO · Director | Gift | 150,000 | — | Form 4 |
| May 27, 2026 | Lyon Joseph Douglas See Remarks | Sale | 5,000 | $325K | Form 4 |
Guyer William
Chief Development Officer
Date
Jun 2
Shares
20,000
Price
$21.65
Value
$433K
Guyer William
Chief Development Officer
Date
Jun 2
Shares
20,000
Price
$70.60
Value
$1.41M ⚡
Guyer William
Chief Development Officer
Date
Jun 1
Shares
877
Price
$70.44
Value
$62K
Robb Gary Charles
Chief Business Officer
Date
Jun 2
Shares
358
Price
$70.44
Value
$25K
Robb Gary Charles
Chief Business Officer
Date
Jun 1
Shares
776
Price
$70.44
Value
$55K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CORT insider trading
CORT insider trades
Corcept Therapeutics Incorporated (CORT) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Maduck Sean (See Remarks), Guyer William (Chief Development Officer), WILSON JAMES N (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. CORT insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Corcept Therapeutics Incorporated's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CORT insider trading · 5 questionsThe insiders of Corcept Therapeutics Incorporated (CORT) include executives and directors such as Maduck Sean (See Remarks), Guyer William (Chief Development Officer), WILSON JAMES N (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026